Stay updated on Vicriviroc and Pembrolizumab in MSS CRC Clinical Trial
Sign up to get notified when there's something new on the Vicriviroc and Pembrolizumab in MSS CRC Clinical Trial page.

Latest updates to the Vicriviroc and Pembrolizumab in MSS CRC Clinical Trial page
- Check3 days agoChange DetectedThe page adds a recruitment status line and new navigation/help sections, updates the Intervention/Treatment heading, and includes a revision tag (Revision: v3.6.0) replacing the previous version.SummaryDifference0.4%

- Check10 days agoChange DetectedThe revision tag on the page was updated from v3.5.4 to v3.5.5, indicating a minor update to the page's version. No substantive study details are affected.SummaryDifference0.0%

- Check17 days agoNo Change Detected
- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedThe page's revision label was updated from v3.5.3 to v3.5.4, signaling a new build or update. This reflects an internal platform or documentation update rather than a change to the study details displayed on the page.SummaryDifference0.0%

- Check52 days agoChange DetectedThe page’s footer “Revision” indicator has been updated from v3.5.2 to v3.5.3.SummaryDifference0.0%

- Check59 days agoChange DetectedPage revision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check74 days agoChange DetectedAdded a related topic for Marinesco-Sjögren syndrome. Included a resources section linking to the Genetic and Rare Diseases Information Center.SummaryDifference0.1%

Stay in the know with updates to Vicriviroc and Pembrolizumab in MSS CRC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Vicriviroc and Pembrolizumab in MSS CRC Clinical Trial page.